Fig. 5From: The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patientsSurvival prognosis of immune-related genes. A, B The survival curve of CCL18 and TRGC1 immune genes showed that the low expression group had a good prognosis. C The high-risk group was associated with poor survival. D The ROC curve confirmed the reliability of the risk survival curve (AUC = 0.610)Back to article page